Conditions: Non-Hodgkin's Lymphoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 17
Healthy volunteers: no

Brief summary:
Non-Hodgin's lymphoma is curable in 76% of patients. In nonlymphoblastic lymphmas, cancer may return on average 3 months from beginning treatment and for lymphoblastic lymphomas, 6 months. To aggressively treat this cancer this study uses effective drugs in three parts:

* Induction ends on day 19
* Consolidation ends on day 38 or 42
* Maintenance may include up to 6 cycles

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNU
Intervention descriptions: intervention 1: LSA4 intervention includes three phases: induction, consolidation and maintenance

Protocol document: